Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Testicular Cancer
Dose: Intravenous – 50-100 mg/m²/day
Frequency: once daily on days 1 through 5
Duration: Repeat every 3-4 weeks
Indication: Testicular Cancer
Dose: Intravenous – 100 mg/m²/day
Frequency: once daily on days 1, 3, and 5
Duration: Repeat every 3-4 weeks

Child Dose

Clinical InformationAdministration Information
Indication: Hodgkin's lymphoma
Age: Child
Dose: Intravenous infusion – 75 to 150 mg/m2/day
Frequency: once daily
Duration: For 2 to 5 days
Indication: non-Hodgkin's lymphoma
Age: Child
Dose: Intravenous infusion – 75 to 150 mg/m2/day
Frequency: once daily
Duration: For 2 to 5 days

Renal Dose

Clinical InformationAdministration Information
Condition: Renal Impairment with Creatinine Clearance greater than 50 mL/min
Dose: Not specified
Note: Dose adjustment not necessary
Condition: Renal Impairment with Creatinine Clearance 15-50 mL/min
Dose: Not specified
Note: 75% of regular dose
Administration
  • Must be administered by healthcare professionals
  • Follow strict medical supervision
Side Effect

Drug Interaction

Drug NameRisk Factors
Other cytotoxic drugs
Synergism
Drugs that inhibit phosphatase activity
Caution when administered together

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.